Panel Overview of Psychedelic Medicines: Iboga, Ketamine, Psilocybin, Ayahuasca, and MDMA

Psychedelic medicines offer potential to treat conditions like post-traumatic stress disorder, depression, and pain by fostering access to authentic selfhood and improved social cohesion. Rather than acting as simple "pills" that cure, these substances facilitate intense, transformative peak experiences. The lasting benefits are contingent upon the choices made after these experiences, such as how someone chooses to live, love, and relate to their community. Integrating these powerful substances into clinical and traditional healing frameworks presents opportunities to address systemic trauma and foster deeper emotional connection. Indigenous traditions often use these medicines for socialization and transmission of communal knowledge, pointing toward possibilities for broader, more inclusive models of healing beyond the limitations of current medical practices.